Mateos, Maria-Victoria Spencer, Andrew Nooka, Ajay K Pour, Ludek Weisel, Katja Cavo, Michele Laubach, Jacob P Cook, Gordon Iida, Shinsuke Benboubker, Lotfi others, Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies, Haematologica-the hematology journal, (105), 468, 2020, Ferrata Storti Foundation,